Facebook Youtube Instagram
  • +91-9866908086, +91-9494138086
  • info@bestbiotechindia.com
  • info@bestbiotechindia.com
JOIN US
JOB OPENINGS
Contact Us

XTAGEST-DG

Tablet

Composition:

Dienogest 2 mg Tablets

Pack Type:

10 X 10

Short Discription:

Targeted Dienogest 2mg tablets for long-term endometriosis management, suppressing pelvic pain and regressing ectopic endometrial lesions.

SKU: 4396 Category: Tags: , , , , , , , , , , , , , , , , , , ,
XTAGEST-DG Tablets (Dydrobest Division) represent a targeted progestin therapy designed for the comprehensive management of endometriosis and associated chronic pelvic pain. Containing 2 mg of Dienogest—a selective progestin with high-potency endometrial activity—XTAGEST-DG offers an effective, long-term medical solution for regressing ectopic endometrial tissue. Unlike combined hormonal regimens or aggressive hormone-blocking therapies, XTAGEST-DG creates an optimal hypoestrogenic microenvironment that starves endometriotic lesions without inducing severe bone density loss or systemic androgenic side effects. It provides continuous relief from dysmenorrhea, dyspareunia, and chronic pelvic discomfort, helping restore quality of life and supporting reproductive health in women managing complex gynecological conditions, including those evaluated alongside PMOS (formerly, PCOS) and pelvic inflammatory states.
  • Progesterone Receptor Agonism: Binds selectively to human progesterone receptors, exerting a potent local progestagenic effect on eutopic and ectopic endometrial tissues.
  • Estrogen Suppression: Moderately suppresses endogenous estradiol synthesis, creating a hypoestrogenic endocrine environment that deprives endometriotic lesions of trophic estrogenic stimulation.
  • Decidualization & Tissue Atrophy: Induces decidualization of endometrial tissue followed by progressive atrophy, causing regression and shrinkage of ectopic endometriotic implants.
  • Anti-Inflammatory & Anti-Angiogenic Activity: Downregulates local inflammatory cytokines, prostaglandin synthesis, and neovascularization within endometriotic foci, directly alleviating severe pelvic pain and tissue swelling.
  • Management of chronic pelvic pain associated with mild, moderate, or severe Endometriosis
  • Regression and suppression of endometriotic lesions and ovarian endometriomas
  • Long-term medical therapy to prevent post-surgical recurrence of endometriotic tissue (as advised by a gynecologist)
  • Dysmenorrhea associated with endometriosis
  • Dyspareunia due to endometriosis
  • Relief from severe secondary dysmenorrhea and dyspareunia (painful intercourse)
  • Supportive progestin therapy in hormonal dysregulation related to endometrial hyperplasia and PMOS (formerly, PCOS) under specialist direction

Standard Dosage: One tablet (2 mg) daily, taken continuously at the same time each day without any pill-free breaks.

Administration: Swallow whole with a glass of water, with or without food. Treatment can begin on any day of the menstrual cycle and must continue uninterrupted regardless of light vaginal bleeding or spotting.

To be taken strictly under the prescription, diagnosis, and supervision of a registered Gynaecologist.

Related Product